Nancy Joseph-Ridge

Nancy has more than 25 years of experience in academic clinical research and the pharmaceutical industry. Previously, Nancy was at Takeda with senior level management experience that included being a Corporate Officer and an R&D Executive. She was head of CNS, Immunology and Rheumatology therapeutic areas, responsible for all strategic aspects of R&D for those areas. She was also head of Global Development and was responsible for all aspects of drug development of pipeline and marketed compounds, including clinical sciences, clinical operations, medical, regulatory, pharmacovigilance, project management and quality.

Prior to that, Nancy was President Takeda Global R&D U.S., Vice-President of R&D at TAP Pharmaceuticals, and she held various positions in clinical development at Searle/Pharmacia.

Prior to working in the pharmaceutical industry, she was an Assistant Professor of Medicine at Rush Medical Center and an Assistant Professor of Clinical Medicine at University of Chicago.

Nancy previously served on the Board of iBIO Institute and was chairperson for two years. She also served on the PhRMA Scientific and Regulatory Committee and Chicago Technology Industry Diversity Council.

Nancy received her medical degree from University of Illinois, completed internship and residency in Internal Medicine and was chief resident at Rush Medical Center and then completed fellowship in Rheumatology at University of Chicago. She received Board certifications in Internal Medicine and Rheumatology. Nancy has been a member of various professional societies and is currently a Fellow Member of the American College of Rheumatology.